(Q73456657)

English

Six-month treatment of obesity with sibutramine 15 mg; a double-blind, placebo-controlled monocenter clinical trial in a Hispanic population

scientific article published on 01 January 2000

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10678261%20AND%20SRC:MED&resulttype=core&format=json

4 November 2019

Six-month treatment of obesity with sibutramine 15 mg; a double-blind, placebo-controlled monocenter clinical trial in a Hispanic population (English)

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10678261%20AND%20SRC:MED&resulttype=core&format=json

4 November 2019

1 reference

based on heuristic

inferred from title

(RS)-sibutramine

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

author name string

Cuellar GE

1

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10678261%20AND%20SRC:MED&resulttype=core&format=json

4 November 2019

Ruiz AM

2

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10678261%20AND%20SRC:MED&resulttype=core&format=json

4 November 2019

Monsalve MC

3

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10678261%20AND%20SRC:MED&resulttype=core&format=json

4 November 2019

Berber A

4

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10678261%20AND%20SRC:MED&resulttype=core&format=json

4 November 2019

publication date

1 January 2000

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10678261%20AND%20SRC:MED&resulttype=core&format=json

4 November 2019

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10678261%20AND%20SRC:MED&resulttype=core&format=json

4 November 2019

8

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10678261%20AND%20SRC:MED&resulttype=core&format=json

4 November 2019

71-82

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10678261%20AND%20SRC:MED&resulttype=core&format=json

4 November 2019

1

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10678261%20AND%20SRC:MED&resulttype=core&format=json

4 November 2019

Overweight and obesity in the United States: prevalence and trends, 1960-1994

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2000.10

31 March 2020

Prevalence of diabetes, impaired fasting glucose, and impaired glucose tolerance in U.S. adults. The Third National Health and Nutrition Examination Survey, 1988-1994.

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2000.10

31 March 2020

Blood pressure in Mexican Americans, whites, and blacks. The Second National Health and Nutrition Examination Survey and the Hispanic Health and Nutrition Examination Survey

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2000.10

31 March 2020

Epidemiology of stroke in Hispanic Americans

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2000.10

31 March 2020

Lipids, lipoproteins and coronary heart disease in minority populations

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2000.10

31 March 2020

Differential impact of obesity in related populations

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2000.10

31 March 2020

Sibutramine reduces food intake in non-dieting women with obesity

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2000.10

31 March 2020

Effects of sibutramine on resting metabolic rate and weight loss in overweight women.

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2000.10

31 March 2020

Thermogenic effects of sibutramine in humans

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2000.10

31 March 2020

A double-blind randomized placebo-controlled trial of sibutramine

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2000.10

31 March 2020

Long-term pharmacotherapy in the management of obesity. National Task Force on the Prevention and Treatment of Obesity

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2000.10

31 March 2020

A review of long-term studies evaluating the efficacy of weight loss in ameliorating disorders associated with obesity

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2000.10

31 March 2020

A commentary on weighing the options: criteria for evaluating weight-management programs.

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2000.10

31 March 2020

Efficacy and tolerability of sibutramine in obese patients: a dose-ranging study

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2000.10

31 March 2020

Sibutramine produces dose-related weight loss.

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2000.10

31 March 2020

Genetic and Environmental Determinants of Type II Diabetes in Mexico City and San Antonio

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2000.10

31 March 2020

Insulin resistance in Mexican Americans--a precursor to obesity and diabetes?

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2000.10

31 March 2020

Performance of semiquantitative food frequency questionnaires in international comparisons. Mexico City versus San Antonio, Texas.

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2000.10

31 March 2020

Prevalence of hypertension in Mexico City and San Antonio, Texas

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2000.10

31 March 2020

Sibutramine. A review of its contribution to the management of obesity.

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2000.10

31 March 2020

Evaluation of drugs for treating obesity

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2000.10

31 March 2020

Identifiers

10.1038/OBY.2000.10

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10678261%20AND%20SRC:MED&resulttype=core&format=json

4 November 2019

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10678261%20AND%20SRC:MED&resulttype=core&format=json

4 November 2019

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q73456657&oldid=2066231582"